Stock Taper
CHRN
CHRONOSCALE CORPORATION
NASDAQ
$20.42
▲ UP 1.44% (0.29)

KEY STATISTICS

Market Cap$72.76 M
52w High$30.00
52w Low$3.50
Dividend Yield
Frequency
P/E-3.60
Volume118.13K
Shares Out.3.56M

COMPANY

LEADERSHIP

Ying Cenly Chen
CHIEF EXECUTIVE
Ying Cenly Chen

ABOUT

SECTOR
Technology
WENT PUBLIC
May 5, 2026
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
86

PRICE TARGET

Target High$32.00
Target Low$32.00
Target Median$32.00
Target Consensus$32.00

UPCOMING EARNINGS

DateSep 21, 2026
DayMonday
Rev. Est.$5.40M
SEP
21
MON

SPLIT RECORD

DATETYPERATIO
2025-06-02Reverse1:15
2020-03-25Reverse1:15
2016-05-05Reverse1:7

PRICE

$20.42 ▲ UP 1.44% (+$0.29)
OVERLAYS
$19.75$20.00$20.25$20.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM20.42

About ChronoScale Corporation

https://chronoscale.com ↗

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeleton technology for healthcare and industrial markets, and is based in San Rafael, CA.

INDUSTRY

Information Technology Services

A PRODUCT CHRONOSCALE CORPORATION IS KNOWN FOR

EksoNR with GaitCoach
EksoNR with GaitCoach

EksoNR is a neurorehabilitation robotic exoskeleton featuring GaitCoach software that offers therapists real-time feedback to enhance patients' walking gait, marking Ekso Bionics' leading medical robotics product.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING
4
LISTED HERE
4
RANKED BY POSITION SIZE

INSIDER TRADES

OFFICER: CHIEF FINANCIAL OFFICER
Wong Jerome
Purchase · 300.0K shares
2026-08-16
OFFICER: CHIEF TECHNOLOGY OFFICER
Jegannathan Rajasekar
· —
2026-07-19
OFFICER: CHIEF TECHNOLOGY OFFICER
Jegannathan Rajasekar
Purchase · 1.4M shares
2026-07-22
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Chen Ying Cenly
Purchase · 2.8M shares
2026-07-13